The group's principal activity is to market technologies based on animal genetics and gene engineering, through its acquisition of eternal technology group. The group is an agricultural genetics and bio-pharmaceutical company operating in China and focused on the development and application of advanced animal husbandry and pharmaceutical techniques to produce improved and novel food and pharmaceutical products. In the fourth quarter of 2003, expanded our embryo transfer and breeding services to include, in addition to sheep, high-yielding pure-bread dairy cattle and also commenced the production and sale of mutton.
